Ripa Marco Ricercatore a tempo determinatoMedicineMED/17
Biography
Publications
Biography
Medical Doctor Degree, Università Vita-Salute San Raffaele, 2012.
Specialist Medical Training, Infectious Diseases, Università Vita-Salute San Raffaele, 2018
Infectious Disease Consultant, Unit of Infectious and Tropical Diseases, Ospedale San Raffaele, 2018
Researcher, Infectious Diseases, (MED/17), 2019
ORCID ID: 0000-0002-6380-0377
Research areas:
- Infective endocarditis
- Bloodstream infections
- Nosocomial infections
- Sepsis and septic shock
Publications
1: Ripa M, Chiappetta S, Castiglioni B, Agricola E, Busnardo E, Carletti S,
Castiglioni A, De Bonis M, La Canna G, Oltolini C, Pajoro U, Pasciuta R, Tassan
Din C, Scarpellini P; Ospedale San Raffaele Endocarditis Team. Impact of
surgical timing on survival in patients with infective endocarditis: a time-
dependent analysis. Eur J Clin Microbiol Infect Dis. 2021 Jan 7. doi:
10.1007/s10096-020-04133-x. Epub ahead of print. PMID: 33411176.
2: Oltolini C, Piemontese S, Ripa M, Greco R, Nozza S, Corti C, Peccatori J,
Scarpellini P, Ciceri F, Castagna A. Allogeneic bone marrow transplantation in
HIV people with hematological malignancies: Post-transplant cyclophosphamide to
overcome the HLA-matching barrier. Transpl Infect Dis. 2020 Dec 22:e13551. doi:
10.1111/tid.13551. Epub ahead of print. PMID: 33351984.
3: Spagnuolo V, Guffanti M, Galli L, Poli A, Querini PR, Ripa M, Clementi M,
Scarpellini P, Lazzarin A, Tresoldi M, Dagna L, Zangrillo A, Ciceri F, Castagna
A; COVID-BioB study group. Viral clearance after early corticosteroid treatment
in patients with moderate or severe covid-19. Sci Rep. 2020 Dec 4;10(1):21291.
doi: 10.1038/s41598-020-78039-1. PMID: 33277573; PMCID: PMC7718220.
4: Ripa M, Galli L, Poli A, Oltolini C, Spagnuolo V, Mastrangelo A, Muccini C,
Monti G, De Luca G, Landoni G, Dagna L, Clementi M, Rovere Querini P, Ciceri F,
Tresoldi M, Lazzarin A, Zangrillo A, Scarpellini P, Castagna A; COVID-BioB study
group. Secondary infections in patients hospitalized with COVID-19: incidence
and predictive factors. Clin Microbiol Infect. 2020 Oct
24:S1198-743X(20)30652-2. doi: 10.1016/j.cmi.2020.10.021. Epub ahead of print.
PMID: 33223114; PMCID: PMC7584496.
5: Mastrangelo A, Germinario BN, Ferrante M, Frangi C, Li Voti R, Muccini C,
Ripa M; COVID-BioB Study Group. Candidemia in COVID-19 patients: incidence and
characteristics in a prospective cohort compared to historical non-COVID-19
controls. Clin Infect Dis. 2020 Oct 30:ciaa1594. doi: 10.1093/cid/ciaa1594. Epub
ahead of print. PMID: 33124650; PMCID: PMC7665423.
6: Rovere-Querini P, Tresoldi C, Conte C, Ruggeri A, Ghezzi S, De Lorenzo R, Di
Filippo L, Farina N, Ramirez GA, Ripa M, Mancini N, Cantarelli E, Galli L, Poli
A, De Cobelli F, Bonini C, Manfredi AA, Franchini S, Spessot M, Carlucci M,
Dagna L, Scarpellini P, Ambrosio A, Di Napoli D, Bosi E, Tresoldi M, Lazzarin A,
Landoni G, Martino G, Zangrillo A, Poli G, Castagna A, Vicenzi E, Clementi M,
Ciceri F; COVID-BioB Study Group. Biobanking for COVID-19 research. Panminerva
Med. 2020 Oct 19. doi: 10.23736/S0031-0808.20.04168-3. Epub ahead of print.
PMID: 33073557.
7: Natalello G, De Luca G, Gigante L, Campochiaro C, De Lorenzis E, Verardi L,
Paglionico A, Petricca L, Martone AM, Calvisi S, Ripa M, Cavalli G, Della-Torre
E, Tresoldi M, Landi F, Bosello SL, Gremese E, Dagna L. Nailfold capillaroscopy
findings in patients with coronavirus disease 2019: Broadening the spectrum of
COVID-19 microvascular involvement. Microvasc Res. 2021 Jan;133:104071. doi:
10.1016/j.mvr.2020.104071. Epub 2020 Sep 17. PMID: 32949574; PMCID: PMC7494493.
8: Oltolini C, Guidetti A, Ripa M, Castiglioni B, Tassan Din C, Mastaglio S,
Canetti D, Monti G, Andolina A, Molinari C, Poloniato A, Mastrangelo A, Ferrante
M, Lanzillotta M, Scarpellini P, Castagna A, Corradini P, Ciceri F. Coronavirus
Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation:
Life-threating Features Within the Early Post-engraftment Phase. Hemasphere.
2020 Aug 10;4(4):e448. doi: 10.1097/HS9.0000000000000448. Erratum in:
Hemasphere. 2020 Sep 16;4(5):e493. PMID: 32885143; PMCID: PMC7430227.
9: Della-Torre E, Campochiaro C, Cavalli G, De Luca G, Napolitano A, La Marca S,
Boffini N, Da Prat V, Di Terlizzi G, Lanzillotta M, Rovere Querini P, Ruggeri A,
Landoni G, Tresoldi M, Ciceri F, Zangrillo A, De Cobelli F, Dagna L; SARI-RAF
Study Group; SARI-RAF Study Group members. Interleukin-6 blockade with sarilumab
in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label
cohort study. Ann Rheum Dis. 2020 Oct;79(10):1277-1285. doi:
10.1136/annrheumdis-2020-218122. Epub 2020 Jul 3. PMID: 32620597; PMCID:
PMC7509526.
10: Iannaccone S, Castellazzi P, Tettamanti A, Houdayer E, Brugliera L, de
Blasio F, Cimino P, Ripa M, Meloni C, Alemanno F, Scarpellini P. Role of
Rehabilitation Department for Adult Individuals With COVID-19: The Experience of
the San Raffaele Hospital of Milan. Arch Phys Med Rehabil. 2020
Sep;101(9):1656-1661. doi: 10.1016/j.apmr.2020.05.015. Epub 2020 Jun 4. PMID:
32505489; PMCID: PMC7272153.
11: Cavalli G, De Luca G, Campochiaro C, Della-Torre E, Ripa M, Canetti D,
Oltolini C, Castiglioni B, Tassan Din C, Boffini N, Tomelleri A, Farina N,
Ruggeri A, Rovere-Querini P, Di Lucca G, Martinenghi S, Scotti R, Tresoldi M,
Ciceri F, Landoni G, Zangrillo A, Scarpellini P, Dagna L. Interleukin-1 blockade
with high-dose anakinra in patients with COVID-19, acute respiratory distress
syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol.
2020 Jun;2(6):e325-e331. doi: 10.1016/S2665-9913(20)30127-2. Epub 2020 May 7.
PMID: 32501454; PMCID: PMC7252085.
12: Campochiaro C, Della-Torre E, Cavalli G, De Luca G, Ripa M, Boffini N,
Tomelleri A, Baldissera E, Rovere-Querini P, Ruggeri A, Monti G, De Cobelli F,
Zangrillo A, Tresoldi M, Castagna A, Dagna L; TOCI-RAF Study Group. Efficacy and
safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective
cohort study. Eur J Intern Med. 2020 Jun;76:43-49. doi:
10.1016/j.ejim.2020.05.021. Epub 2020 May 22. PMID: 32482597; PMCID: PMC7242960.
13: Muscatello A, Nozza S, Fabbiani M, De Benedetto I, Ripa M, Dell'acqua R,
Antinori A, Pinnetti C, Calcagno A, Ferrara M, Focà E, Quiros-Roldan E,
Ripamonti D, Campus M, Maurizio Celesia B, Torti C, Cosco L, Di Biagio A,
Rusconi S, Marchetti G, Mussini C, Gulminetti R, Cingolani A, D'ettorre G,
Madeddu G, Franco A, Orofino G, Squillace N, Gori A, Tambussi G, Bandera A;
Inaction Study Group.. Enhanced Immunological Recovery With Early Start of
Antiretroviral Therapy During Acute or Early HIV Infection-Results of Italian
Network of ACuTe HIV InfectiON (INACTION) Retrospective Study. Pathog Immun.
2020 Feb 24;5(1):8-33. doi: 10.20411/pai.v5i1.341. PMID: 32258852; PMCID:
PMC7104556.
14: Oltolini C, Greco R, Galli L, Clerici D, Lorentino F, Xue E, Lupo
Stanghellini MT, Giglio F, Uhr L, Ripa M, Scarpellini P, Bernardi M, Corti C,
Peccatori J, Castagna A, Ciceri F. Infections after Allogenic Transplant with
Post-Transplant Cyclophosphamide: Impact of Donor HLA Matching. Biol Blood
Marrow Transplant. 2020 Jun;26(6):1179-1188. doi: 10.1016/j.bbmt.2020.01.013.
Epub 2020 Jan 28. PMID: 32004700.
15: Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, Popescu BA,
Prendergast B, Tornos P, Sadeghpour A, Oliver L, Vaskelyte JJ, Sow R, Axler O,
Maggioni AP, Lancellotti P; EURO-ENDO Investigators. Clinical presentation,
aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-
ENDO (European infective endocarditis) registry: a prospective cohort study. Eur
Heart J. 2019 Oct 14;40(39):3222-3232. doi: 10.1093/eurheartj/ehz620. PMID:
31504413.
16: Tascini C, Attanasio V, Ripa M, Carozza A, Pallotto C, Bernardo M, Francisci
D, Oltolini C, Palmiero G, Scarpellini P. Ceftobiprole for the treatment of
infective endocarditis: A case series. J Glob Antimicrob Resist. 2020
Mar;20:56-59. doi: 10.1016/j.jgar.2019.07.020. Epub 2019 Jul 24. PMID: 31351247.
17: Gianotti N, Muccini C, Galli L, Poli A, Spagnuolo V, Andolina A, Galizzi N,
Ripa M, Messina E, Piatti PM, Lazzarin A, Castagna A. Homeostatic model
assessment for insulin resistance index trajectories in HIV-infected patients
treated with different first-line antiretroviral regimens. J Med Virol. 2019
Nov;91(11):1937-1943. doi: 10.1002/jmv.25541. Epub 2019 Jul 16. PMID: 31286527.
18: Habib G, Lancellotti P, Erba PA, Sadeghpour A, Meshaal M, Sambola A, Furnaz
S, Citro R, Ternacle J, Donal E, Cosyns B, Popescu B, Iung B, Prendergast B,
Laroche C, Tornos P, Pazdernik M, Maggioni A, Gale CP; EURO-ENDO Investigators.
The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry. Eur Heart J
Qual Care Clin Outcomes. 2019 Jul 1;5(3):202-207. doi: 10.1093/ehjqcco/qcz018.
Erratum in: Eur Heart J Qual Care Clin Outcomes. 2020 Jan 1;6(1):91. PMID:
30957862.
19: Ferrari D, Ripa M, Premaschi S, Banfi G, Castagna A, Locatelli M. LC-MS/MS
method for simultaneous determination of linezolid, meropenem, piperacillin and
teicoplanin in human plasma samples. J Pharm Biomed Anal. 2019 May 30;169:11-18.
doi: 10.1016/j.jpba.2019.02.037. Epub 2019 Feb 21. PMID: 30826487.
20: Ripa M, Morata L, Rodríguez-Núñez O, Cardozo C, Puerta-Alcalde P, Hernández-
Meneses M, Ambrosioni J, Linares L, Bodro M, Valcárcel A, Casals C, Guerrero-
León MLA, Almela M, Garcia-Vidal C, Del Río A, Marco F, Mensa J, Martínez JA,
Soriano A. Short-Term Peripheral Venous Catheter-Related Bloodstream Infections:
Evidence for Increasing Prevalence of Gram-Negative Microorganisms from a
25-Year Prospective Observational Study. Antimicrob Agents Chemother. 2018 Oct
24;62(11):e00892-18. doi: 10.1128/AAC.00892-18. PMID: 30126952; PMCID:
PMC6201066.
21: Oltolini C, Ripa M, Andolina A, Brioschi E, Cilla M, Petrella G, Gregorc V,
Castiglioni B, Tassan Din C, Scarpellini P. Invasive Pulmonary Aspergillosis
Complicated by Carbapenem-Resistant Pseudomonas aeruginosa Infection During
Pembrolizumab Immunotherapy for Metastatic Lung Adenocarcinoma: Case Report and
Review of the Literature. Mycopathologia. 2019 Feb;184(1):181-185. doi:
10.1007/s11046-018-0291-4. Epub 2018 Aug 13. PMID: 30101407.
22: Rodríguez-Núñez O, Ripa M, Morata L, de la Calle C, Cardozo C, Fehér C,
Pellicé M, Valcárcel A, Puerta-Alcalde P, Marco F, García-Vidal C, Del Río A,
Soriano A, Martínez-Martínez JA. Evaluation of ceftazidime/avibactam for serious
infections due to multidrug-resistant and extensively drug-resistant Pseudomonas
aeruginosa. J Glob Antimicrob Resist. 2018 Dec;15:136-139. doi:
10.1016/j.jgar.2018.07.010. Epub 2018 Jul 20. PMID: 30036695.
23: Gianotti N, Galli L, Galizzi N, Ripa M, Andolina A, Nozza S, Spagnuolo V,
Poli A, Lazzarin A, Castagna A. Time spent with residual viraemia after
virological suppression below 50 HIV-RNA copies/mL according to type of first-
line antiretroviral regimen. Int J Antimicrob Agents. 2018 Oct;52(4):492-499.
doi: 10.1016/j.ijantimicag.2018.07.001. Epub 2018 Sep 13. PMID: 30009958.
24: Ramirez GA, Yacoub MR, Ripa M, Mannina D, Cariddi A, Saporiti N, Ciceri F,
Castagna A, Colombo G, Dagna L. Eosinophils from Physiology to Disease: A
Comprehensive Review. Biomed Res Int. 2018 Jan 28;2018:9095275. doi:
10.1155/2018/9095275. PMID: 29619379; PMCID: PMC5829361.
25: Ripa M, Rodríguez-Núñez O, Cardozo C, Naharro-Abellán A, Almela M, Marco F,
Morata L, De La Calle C, Del Rio A, Garcia-Vidal C, Ortega MDM, Guerrero-León
MLA, Feher C, Torres B, Puerta-Alcalde P, Mensa J, Soriano A, Martínez JA.
Influence of empirical double-active combination antimicrobial therapy compared
with active monotherapy on mortality in patients with septic shock: a propensity
score-adjusted and matched analysis. J Antimicrob Chemother. 2017 Dec
1;72(12):3443-3452. doi: 10.1093/jac/dkx315. PMID: 28961801.
Il titolare del presente curriculum vitae, pubblicato online sul portale www.unisr.it, è garante in via esclusiva della correttezza e della veridicità dei dati e delle informazioni in esso riportate e del loro eventuale e puntuale aggiornamento. Egli è dunque il diretto ed unico responsabile dei contenuti indicati nei propri curricula.